Arenșia Exploratory Medicine is a prominent European Clinical Research Organization (CRO) specializing in early phase (Phase I, Ib, IIa) clinical trials. They are renowned for their patient-centric approach and a unique network of dedicated research clinics across several countries, primarily in Eastern Europe, with a growing presence in the USA. Arenșia focuses on conducting complex studies for novel therapeutics across various indications, aiming to accelerate drug development by providing high-quality data and efficient patient recruitment, particularly in challenging patient populations.
The Düsseldorf headquarters serves as the central hub for global operations management, strategic planning, business development, quality assurance oversight, and administrative functions supporting its network of clinical research sites.
The office is situated in a modern business district, likely equipped with state-of-the-art communication and administrative facilities to manage a geographically dispersed network of research clinics.
The work culture at Arenșia's headquarters is likely professional, scientifically driven, and internationally oriented, fostering collaboration between diverse teams to ensure high standards in clinical research execution and patient safety. Emphasis is placed on precision, efficiency, and ethical conduct.
The Düsseldorf HQ is strategically significant due to Germany's strong pharmaceutical industry, central European location facilitating easy access to other European countries, and a robust regulatory environment. It positions Arenșia well for collaboration with global pharma and biotech companies.
Arenșia Exploratory Medicine supports global drug development programs by operating a network of state-of-the-art, dedicated Phase I/IIa clinical research clinics primarily located in Germany, Moldova, Ukraine, Georgia, Romania, and the USA. Their functions supported globally include patient recruitment and retention for complex studies, clinical trial conduct, medical monitoring, data management, and quality assurance, all adhering to ICH-GCP guidelines and international regulatory standards.
Grafenberger Allee 295
Düsseldorf
North Rhine-Westphalia
Germany
Address: Str. Nicolae Testemițanu 29, Chișinău 2025, Moldova (Typical for their clinic locations)
Provides access to specific patient populations in Moldova and surrounding regions, enhancing recruitment capabilities for complex early-phase studies.
Address: Specific clinic addresses vary; operations across major medical centers.
Leverages Ukraine's established medical infrastructure and patient pool for efficient clinical trial execution, despite ongoing regional challenges.
Address: E.g., 1 Aleksandr Kazbegi Ave, Tbilisi, Georgia (Representative clinic location area)
Expands Arenșia's reach in the Caucasus region, tapping into local patient demographics for diverse trial needs.
Address: Multiple locations, often co-located with major hospitals.
Strengthens presence in Southeastern Europe, accessing a large and diverse patient population for clinical research.
Address: Kendall Square area (Typical for biotech/pharma presence)
Serves as a key interface with the US pharmaceutical market, facilitating partnerships and expanding clinical trial activities into North America.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, ARENSIA Exploratory Medicine GmbH' leadership includes:
ARENSIA Exploratory Medicine GmbH has been backed by several prominent investors over the years, including:
In late 2023, Arenșia Exploratory Medicine was acquired by Arsenal Capital Partners, which may lead to strategic executive alignments, although specific new hires or exits directly tied to this and publicly announced in the last 12 months are minimal. The core leadership team appears largely consistent.
Discover the tools ARENSIA Exploratory Medicine GmbH uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Arenșia Exploratory Medicine likely uses standard professional email formats. Common patterns include [first_initial][last_name]@[company_domain] or [first_name].[last_name]@[company_domain].
[first_initial][last]@arensia.com or [first].[last]@arensia.com
Format
cfilozof@arensia.com
Example
85%
Success rate
PR Newswire • October 4, 2023
Arsenal Capital Partners, a private equity firm specializing in industrial growth and healthcare companies, announced its acquisition of a majority interest in Arenșia Exploratory Medicine. This partnership aims to accelerate Arenșia's growth and expand its global clinical research capabilities....more
Arenșia Website News • March 15, 2023
Arenșia announced the expansion of its operations into the United States with the opening of a new, state-of-the-art research clinic in Cypress, California. This marks a significant step in their global growth strategy, aiming to serve US-based biotech and pharma companies....more
European Pharmaceutical Review • September 19, 2023
Arenșia Exploratory Medicine continues its expansion with the announcement of a new research clinic, further enhancing its capacity to conduct complex early-phase clinical trials across various therapeutic areas. This development underscores their commitment to accelerating drug development....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including ARENSIA Exploratory Medicine GmbH, are just a search away.